MétaCan
Menu
Back to cohort
Record W2046733598 · doi:10.1016/j.bbmt.2014.10.006

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

2014· article· en· W2046733598 on OpenAlexaff
Christine Duncan, Navneet S. Majhail, Ruta Brazauskas, Zhiwei Wang, Jean‐Yves Cahn, Haydar Frangoul, Robert J. Hayashi, Jack W. Hsu, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Alison W. Loren, David I. Marks, Richard T. Maziarz, Paulette Mehta, Kasiani C. Myers, Maxim Norkin, Joseph A. Pidala, David L. Porter, Vijay Reddy, Wael Saber, Bipin N. Savani, Harry C. Schouten, Amir Steinberg, Donna A. Wall, Anne B. Warwick, William A. Wood, Lolie C. Yu, David A. Jacobsohn, Mohamed L. Sorror

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2014
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsCancerCare ManitobaUniversity of Manitoba
FundersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteOffice of Naval ResearchNational Heart, Lung, and Blood InstituteTerumo BCTGenentechSeattle GeneticsCellGenixKiadis PharmaTherakosSigma-Tau PharmaceuticalsMedical College of WisconsinTarix PharmaceuticalsStemCyteBlue Cross and Blue Shield AssociationSwedish Orphan BiovitrumNational Center for Advancing Translational SciencesWellPointOsiris TherapeuticsCelgeneOtsuka America PharmaceuticalAmgenAriad PharmaceuticalsGlaxoSmithKlineMerckSanofiNational Marrow Donor ProgramLeukemia and Lymphoma SocietyBe The Match Foundation
KeywordsMedicineCumulative incidenceTransplantationHazard ratioMyelodysplastic syndromesInternal medicineHematopoietic stem cell transplantationCohortIncidence (geometry)Hematopoietic cellLeukemiaDiseaseRegimenPediatricsStem cellHaematopoiesisConfidence intervalBone marrow

Abstract

fetched live from OpenAlex

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second allogeneic hematopoietic cell transplantation (HCT) for relapsed acute leukemia or myelodysplastic syndromes between 1980 and 2009. A total of 1285 patients received a second allogeneic transplant after disease relapse; among these, 325 were relapse free at 1 year after the second HCT. The median time from first to second HCT was 17 and 24 months for children and adults, respectively. A myeloablative preparative regimen was used in the second transplantation in 62% of children and 45% of adult patients. The overall 10-year conditional survival rates after second transplantation in this cohort of patients who had survived disease-free for at least 1 year was 55% in children and 39% in adults. Relapse was the leading cause of mortality (77% and 54% of deaths in children and adults, respectively). In multivariate analyses, only disease status before second HCT was significantly associated with higher risk for overall mortality (hazard ratio, 1.71 for patients with disease not in complete remission before second HCT, P < .01). Chronic graft-versus-host disease (GVHD) developed in 43% and 75% of children and adults after second transplantation. Chronic GVHD was the leading cause of nonrelapse mortality, followed by organ failure and infection. The cumulative incidence of developing at least 1 of the studied late effects within 10 years after second HCT was 63% in children and 55% in adults. The most frequent late effects in children were growth disturbance (10-year cumulative incidence, 22%) and cataracts (20%); in adults they were cataracts (20%) and avascular necrosis (13%). Among patients with acute leukemia and myelodysplastic syndromes who receive a second allogeneic HCT for relapse and survive disease free for at least 1 year, many can be expected to survive long term. However, they continue to be at risk for relapse and nonrelapse morbidity and mortality. Novel approaches are needed to minimize relapse risk and long-term transplantation morbidity in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.230
Teacher spread0.222 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations64
Published2014
Admission routes1
Has abstractno

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicHematopoietic Stem Cell TransplantationFrench-language works237,207